ADELAIDE, Australia--(BUSINESS WIRE)--TGR BioSciences announces expansion of the extremely successful and proven ‘No-wash’ SureFire® portfolio by addition of 9 new cell pathway analysis kits for measurement of phospho-proteins. The SureFire® technology is an exquisitely sensitive assay system which utilizes PerkinElmer’s ALPHA/Amplified Luminescent Proximity Homogeneous Assay detection chemistry. The SureFire® technology is widely employed by many of the world’s leading pharmaceutical and biotechnology companies in the development of new drugs and therapies for numerous diseases including cancer. The SureFire® range now includes over 60 SureFire® kits and is available exclusively through TGR’s commercial partner, PerkinElmer.
